Initial general form for registration of a class of securities pursuant to Section 12(g)

Description of Business (Details Narrative)

v3.22.2
Description of Business (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 25, 2021
Jun. 09, 2021
Sep. 30, 2021
Dec. 31, 2021
Stock Issued During Period, Value, New Issues      
Voting percent   51.00%    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   0.84%    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   250.00%    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term   5 years    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions   35.00%    
Stock Issued During Period, Shares, Conversion of Convertible Securities   14,465,259    
Mr. Gerard Dab [Member]        
Number of shares exchanged   $ 200,000    
Stock Repurchased During Period, Value   $ 122,000    
Series B Convertible Redeemable Preferred Stock [Member]        
Percentage of Shares for Conversion 4.99%      
Series A Supermajority Voting Preferred Stock [Member]        
Stock Issued During Period, Shares, Acquisitions   1,000    
Series A Supermajority Voting Preferred Stock [Member] | Mr. Gerard Dab [Member]        
Number of shares exchanged   $ 300,000    
Series C Convertible Redeemable Preferred Stock [Member]        
Stock Issued During Period, Shares, Acquisitions   200    
Rennova Health, Inc. [Member] | Series B Convertible Redeemable Preferred Stock [Member]        
Sale of Stock, Number of Shares Issued in Transaction 14,000   950  
Preferred Stock, Par or Stated Value Per Share $ 1,000      
Stock Issued During Period, Shares, New Issues 14,950      
Stock Issued During Period, Value, New Issues $ 9,086,396